Literature DB >> 8855299

Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice.

E Hirsch1, V M Irikura, S M Paul, D Hirsh.   

Abstract

Interleukin 1 receptor antagonist (IL-1ra) is a cytokine whose only known action is competitive inhibition of the binding of interleukin 1 (IL-1) to its receptor. To investigate the physiological roles of endogenously produced IL-1ra, we generated mice that either lack IL-1ra or overproduce it under control of the endogenous promoter. Mice lacking IL-1ra have decreased body mass compared with wild-type controls. They are more susceptible than controls to lethal endotoxemia but are less susceptible to infection with Listeria monocytogenes. Conversely, IL-1ra overproducers are protected from the lethal effects of endotoxin but are more susceptible to listeriosis. Serum levels of IL-1 following an endotoxin challenge are decreased in IL-1ra nulls and increased in IL-1ra overproducers in comparison to controls. These data demonstrate critical roles for endogenously produced IL-1ra in growth, responses to infection and inflammation, and regulation of cytokine expression.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8855299      PMCID: PMC38274          DOI: 10.1073/pnas.93.20.11008

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis.

Authors:  J A Eastgate; J A Symons; N C Wood; F M Grinlinton; F S di Giovine; G W Duff
Journal:  Lancet       Date:  1988-09-24       Impact factor: 79.321

2.  Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor.

Authors:  C H Hannum; C J Wilcox; W P Arend; F G Joslin; D J Dripps; P L Heimdal; L G Armes; A Sommer; S P Eisenberg; R C Thompson
Journal:  Nature       Date:  1990-01-25       Impact factor: 49.962

3.  Effects of murine recombinant interleukin 1 alpha on the host response to bacterial infection.

Authors:  C J Czuprynski; J F Brown; K M Young; A J Cooley; R S Kurtz
Journal:  J Immunol       Date:  1988-02-01       Impact factor: 5.422

4.  Suppression of experimental arthritis by gene transfer of interleukin 1 receptor antagonist cDNA.

Authors:  S S Makarov; J C Olsen; W N Johnston; S K Anderle; R R Brown; A S Baldwin; J S Haskill; J H Schwab
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

5.  Interleukin-1 receptor antagonist reduces mortality from endotoxin shock.

Authors:  K Ohlsson; P Björk; M Bergenfeldt; R Hageman; R C Thompson
Journal:  Nature       Date:  1990-12-06       Impact factor: 49.962

6.  Interleukin 1 participates in the development of anti-Listeria responses in normal and SCID mice.

Authors:  H W Rogers; K C Sheehan; L M Brunt; S K Dower; E R Unanue; R D Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-01       Impact factor: 11.205

7.  Interleukin 1 induces interleukin 1. I. Induction of circulating interleukin 1 in rabbits in vivo and in human mononuclear cells in vitro.

Authors:  C A Dinarello; T Ikejima; S J Warner; S F Orencole; G Lonnemann; J G Cannon; P Libby
Journal:  J Immunol       Date:  1987-09-15       Impact factor: 5.422

8.  Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction.

Authors:  D J Dripps; B J Brandhuber; R C Thompson; S P Eisenberg
Journal:  J Biol Chem       Date:  1991-06-05       Impact factor: 5.157

9.  Pro- and anti-inflammatory roles of interleukin-1 in recurrence of bacterial cell wall-induced arthritis in rats.

Authors:  J H Schwab; S K Anderle; R R Brown; F G Dalldorf; R C Thompson
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

10.  Interleukin 1 potentiates the lethal effect of tumor necrosis factor alpha/cachectin in mice.

Authors:  A Waage; T Espevik
Journal:  J Exp Med       Date:  1988-06-01       Impact factor: 14.307

View more
  78 in total

Review 1.  Control of body weight: a physiologic and transgenic perspective.

Authors:  G Frühbeck; J Gómez-Ambrosi
Journal:  Diabetologia       Date:  2003-02-15       Impact factor: 10.122

2.  Importance of interleukin-1 and interleukin-1 receptor antagonist in short-term glucose sensor function in vivo.

Authors:  Ulrike Klueh; Zenghe Liu; Ben Feldman; Don Kreutzer
Journal:  J Diabetes Sci Technol       Date:  2010-09-01

3.  CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity.

Authors:  Justin T Rogers; Josh M Morganti; Adam D Bachstetter; Charles E Hudson; Melinda M Peters; Bethany A Grimmig; Edwin J Weeber; Paula C Bickford; Carmelina Gemma
Journal:  J Neurosci       Date:  2011-11-09       Impact factor: 6.167

Review 4.  Understanding rheumatic fever.

Authors:  Pedro Ming Azevedo; Rosa Rodrigues Pereira; Luiza Guilherme
Journal:  Rheumatol Int       Date:  2011-09-28       Impact factor: 2.631

Review 5.  Hypothalamic mechanisms in cachexia.

Authors:  Aaron J Grossberg; Jarrad M Scarlett; Daniel L Marks
Journal:  Physiol Behav       Date:  2010-03-25

6.  PhosphoCREB and CREM/ICER: positive and negative regulation of proenkephalin gene expression in the paraventricular nucleus of the hypothalamus.

Authors:  D Borsook; O Smirnova; O Behar; S Lewis; L A Kobierski
Journal:  J Mol Neurosci       Date:  1999-02       Impact factor: 3.444

7.  IL-1R Regulates Disease Tolerance and Cachexia in Toxoplasma gondii Infection.

Authors:  Stephanie J Melchor; Claire M Saunders; Imani Sanders; Jessica A Hatter; Kari A Byrnes; Sheryl Coutermarsh-Ott; Sarah E Ewald
Journal:  J Immunol       Date:  2020-04-29       Impact factor: 5.422

8.  Delayed resolution of lung inflammation in Il-1rn-/- mice reflects elevated IL-17A/granulocyte colony-stimulating factor expression.

Authors:  Kristin M Hudock; Yuhong Liu; Junjie Mei; Roberta C Marino; Jason E Hale; Ning Dai; G Scott Worthen
Journal:  Am J Respir Cell Mol Biol       Date:  2012-05-16       Impact factor: 6.914

9.  Imbalances between interleukin-1 and tumor necrosis factor agonists and antagonists in stable COPD.

Authors:  Elizabeth Sapey; Ali Ahmad; Darren Bayley; Paul Newbold; Noel Snell; Paul Rugman; Robert A Stockley
Journal:  J Clin Immunol       Date:  2009-03-17       Impact factor: 8.317

10.  Transcriptome analysis reveals human cytomegalovirus reprograms monocyte differentiation toward an M1 macrophage.

Authors:  Gary Chan; Elizabeth R Bivins-Smith; M Shane Smith; Patrick M Smith; Andrew D Yurochko
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.